Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjustable doses of extended-release paliperidone, in combination with lithium or valproate, versus placebo for manic and mixed episode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)
• Paliperidone ER (paliperidone)
• Valproate (valproate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Affective Psychosis, Bipolar, Bipolar Disorder | Phase 3 | Status: COMPLETED